Anaesthesia management in a child with metabolic myopathy

dc.contributor.authorOzer, A.B.
dc.contributor.authorDemirel, I.
dc.contributor.authorGokdemir, T.
dc.contributor.authorErhan, O.L.
dc.date.accessioned2026-08-12T16:11:28Z
dc.date.issued2014
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.endpage3348
dc.identifier.issn1128-3602
dc.identifier.issue22
dc.identifier.scopus2-s2.0-84942292183
dc.identifier.scopusqualityN/A
dc.identifier.startpage3347
dc.identifier.urihttps://hdl.handle.net/11508/42495
dc.identifier.volume18
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherVerduci Editore
dc.relation.ispartofEuropean Review for Medical and Pharmacological Sciences
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20260511
dc.subjectadenosine triphosphate; carbohydrate; creatine kinase; glucose; nitrous oxide; propofol; remifentanil; rocuronium; sugammadex; thiopental; body temperature; case report; child; human; Letter; male; metabolic myopathy; muscle contraction; muscle weakness; myopathy; oxidative phosphorylation; pediatric anesthesia; preoperative care; school child
dc.titleAnaesthesia management in a child with metabolic myopathy
dc.typeLetter

Dosyalar